India: Ford, Nissan, Toyota penalised for unfair trade practices in spare parts
The competition appellate tribunal Compat on Friday disposed appeals of Ford, Nissan, Toyota Kirloskar, and found them to be guilty of indulging in unfair practices in the spare parts market.
While pronouncing its oral order, Compat said these automakers have been penalised 2% of their turnover in the spare parts market. And what’s more, the Compat has also given directions to create a level playing field in after sales service.
For instance, Compat in its oral order has directed the three automakers to remove all restriction on supply of spare parts, ensure no restrictions on independent repairers, and also provide MRPs on spare parts on company websites. Besides these measures, the Compat wants the Ministry of Road & Transport to ensure standardisation of auto parts.
Advocate Vaibhav Gaggar appeared for the competition watchdog CCI and says, “The judgement should go a long way in bringing about transparency, accessibility and fairness in the auto mobile spare parts sector. This in turn would provide greater competition in the market and significantly promote the interests of consumers.”
The CCI in 2014 had found 14 automakers including Maruti Suzuki, M&M and Tata Motors guilty of anti-competitive practices in the spare parts market and had penalised them Rs 2,545 cr. Nissan, Ford, Toyota Kirloskar had appealed against that at the Compat, while other auto companies chose to appeal at the High Court.
Full Content: Economic Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas